François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Karijn Suijkerbuijk hoogleraar Immunotherapie UMC Utrecht
aug 2022 | Immuuntherapie